Quick Answer
ANAVEX LIFE SCIENCES CORP. reported Net Income Loss of -$46.38 million for the year ending 2025.
- ANAVEX LIFE SCIENCES CORP. showed a decrease of -7.8% in Net Income Loss from 2024 to 2025.
- This data is from ANAVEX LIFE SCIENCES CORP.'s annual report (Form 10-K), filed with the SEC on November 25, 2025.
- XBRL data for this metric is available from 2006 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: -$453.5 thousand | Q1 2013: -$106.1 thousand | Q2 2013: -$151.9 thousand | Q4 2013: $358.6 thousand | Q1 2014: -$1.02 million | Q2 2014: -$1.01 million | Q4 2014: -$786.7 thousand | Q1 2015: -$1.72 million | Q2 2015: -$4.24 million | Q4 2015: -$3.95 million | Q1 2016: -$2.03 million | Q2 2016: -$2.24 million | Q4 2016: -$3.15 million | Q1 2017: -$1.55 million | Q2 2017: -$3.61 million | Q4 2017: -$4.06 million | Q1 2018: -$4.75 million | Q2 2018: -$2.85 million | Q4 2018: -$6.92 million | Q1 2019: -$7.25 million | Q2 2019: -$6.52 million | Q4 2019: -$6.59 million | Q1 2020: -$7.24 million | Q2 2020: -$6.49 million | Q4 2020: -$7.86 million | Q1 2021: -$8.16 million | Q2 2021: -$10.18 million | Q4 2021: -$10.88 million | Q1 2022: -$10.44 million | Q2 2022: -$12.37 million | Q4 2022: -$12.97 million | Q1 2023: -$13.11 million | Q2 2023: -$11.28 million | Q4 2023: -$8.62 million | Q1 2024: -$10.55 million | Q2 2024: -$12.21 million | Q4 2024: -$12.11 million | Q1 2025: -$11.20 million | Q2 2025: -$13.24 million | Q4 2025: -$5.68 million.
- Over the full 20 years of available data (2006 to 2025), ANAVEX LIFE SCIENCES CORP.'s Net Income Loss has declined by 181,542.6%.
- Historical annual values: Fiscal year 2025: -$46.38 million | Fiscal year 2024: -$43.00 million | Fiscal year 2023: -$47.51 million | Fiscal year 2022: -$47.98 million | Fiscal year 2021: -$37.91 million | Fiscal year 2020: -$26.28 million | Fiscal year 2019: -$26.29 million | Fiscal year 2018: -$17.25 million | Fiscal year 2017: -$13.46 million | Fiscal year 2016: -$14.74 million | Fiscal year 2015: -$12.11 million | Fiscal year 2014: -$9.97 million | Fiscal year 2013: -$3.70 million | Fiscal year 2012: -$8.30 million | Fiscal year 2011: -$7.31 million | Fiscal year 2010: -$8.78 million | Fiscal year 2009: -$5.50 million | Fiscal year 2008: -$5.35 million | Fiscal year 2007: -$1.58 million | Fiscal year 2006: -$25.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: